Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Archives of Gynecology and Obstetrics
Erschienen in: Archives of Gynecology and Obstetrics 1/2011

01.07.2011 | Reproductive Medicine

HIV-infection and modern antiretroviral therapy impair sperm quality

verfasst von: Sven Kehl, Michael Weigel, Daniel Müller, Monika Gentili, Amadeus Hornemann, Marc Sütterlin

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Serodiscordant couples with a human immunodeficiency virus type 1 (HIV-1)-infected man request assisted reproductive technology (ART) in order to achieve safe conception. Most of these men are on highly active antiretroviral therapy (HAART). HIV-1 infection and the antiretroviral drugs are blamed for semen alterations. The aim of our study was to investigate the semen parameters in HIV-1-infected patients with and without HAART and to compare their sperm characteristics with those of healthy men.

Materials and methods

A prospective study of 226 men attended the university fertility center of Mannheim between May 1996 and July 2003. The patients were divided into three groups: HIV-infected men taking antiretroviral therapy, HIV-infected patients who did not take antiretroviral therapy until now and a control group with 93 men consulting our fertility center together with their wives because of tubal sterility. Semen samples were examined with regard to ejaculate volume, sperm concentration, motility, and morphology.

Results

The study showed significant differences between the ejaculate of HIV-infected and non-infected men. The HIV-infected men as a whole group and the subgroup of men with HAART had a lower ejaculate volume, less slow progressive and more abnormally shaped spermatozoa compared with the control group. The HIV-infected men without an antiretroviral therapy had a significant lower ejaculate volume compared with the control group; the other parameters were not altered significantly. Differences between the subgroups with and without HAART were not significant.

Conclusion

The spermiogram in HIV-1-infected men in comparison to a control group of healthy men is negatively altered. Especially in men with HAART, ejaculate volume as well as sperm morphology and motility changed significantly.
Literatur
1.
2.
3.
4.
Chu MC, Pena JE, Nakhuda GS, Thornton MH 2nd, Sauer MV (2006) Assessing the reproductive performance of men co-infected with HIV-1 and hepatitis C undergoing assisted reproduction. Arch Gynecol Obstet 274(3):155–159. doi:10.​1007/​s00404-006-0164-9 PubMedCrossRef
5.
Gupta P, Mellors J, Kingsley L, Riddler S, Singh MK, Schreiber S, Cronin M, Rinaldo CR (1997) High viral load in semen of human immunodeficiency virus type 1-infected men at all stages of disease and its reduction by therapy with protease and nonnucleoside reverse transcriptase inhibitors. J Virol 71(8):6271–6275PubMed
6.
Dulioust E, Tachet A, De Almeida M, Finkielsztejn L, Rivalland S, Salmon D, Sicard D, Rouzioux C, Jouannet P (1998) Detection of HIV-1 in seminal plasma and seminal cells of HIV-1 seropositive men. J Reprod Immunol 41(1–2):27–40. S0165-0378(98)00047-3 [pii]PubMedCrossRef
7.
Barroso PF, Schechter M, Gupta P, Melo MF, Vieira M, Murta FC, Souza Y, Harrison LH (2000) Effect of antiretroviral therapy on HIV shedding in semen. Ann Intern Med 133(4):280–284. doi:200008150-00012 PubMed
8.
Taylor S, Ferguson NM, Cane PA, Anderson RM, Pillay D (2001) Dynamics of seminal plasma HIV-1 decline after antiretroviral treatment. AIDS 15(3):424–426PubMedCrossRef
9.
Leruez-Ville M, de Almeida M, Tachet A, Dulioust E, Guibert J, Mandelbrot L, Salmon D, Jouannet P, Rouzioux C (2002) Assisted reproduction in HIV-1-serodifferent couples: the need for viral validation of processed semen. AIDS 16(17):2267–2273PubMedCrossRef
10.
Bujan L, Daudin M, Matsuda T, Righi L, Thauvin L, Berges L, Izopet J, Berrebi A, Massip P, Pasquier C (2004) Factors of intermittent HIV-1 excretion in semen and efficiency of sperm processing in obtaining spermatozoa without HIV-1 genomes. AIDS 18(5):757–766. 00002030-200403260-00006 [pii]PubMedCrossRef
11.
Gupta P, Leroux C, Patterson BK, Kingsley L, Rinaldo C, Ding M, Chen Y, Kulka K, Buchanan W, McKeon B, Montelaro R (2000) Human immunodeficiency virus type 1 shedding pattern in semen correlates with the compartmentalization of viral Quasi species between blood and semen. J Infect Dis 182(1):79–87. doi:10.​1086/​315644 PubMedCrossRef
12.
Zhang H, Dornadula G, Beumont M, Livornese L Jr, Van Uitert B, Henning K, Pomerantz RJ (1998) Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy. N Engl J Med 339(25):1803–1809. doi:10.​1056/​nejm199812173392​502 PubMedCrossRef
13.
Dornadula G, Zhang H, VanUitert B, Stern J, Livornese L Jr, Ingerman MJ, Witek J, Kedanis RJ, Natkin J, DeSimone J, Pomerantz RJ (1999) Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy. JAMA 282(17):1627–1632. joc91532 [pii]PubMedCrossRef
14.
Semprini AE (1993) Insemination of HIV-negative women with processed semen of HIV-positive partners. Lancet 341(8856):1343–1344PubMedCrossRef
15.
Marina S, Marina F, Alcolea R, Expósito R, Huguet J, Nadal J, Vergés A (1998) Human immunodeficiency virus type 1-serodiscordant couples can bear healthy children after undergoing intrauterine insemination. Fertil Steril 70(1):35–39. S0015-0282(98)00102-2 [pii]PubMedCrossRef
16.
Bujan L, Pasquier C, Labeyrie E, Lanusse-Crousse P, Morucci M, Daudin M (2004) Insemination with isolated and virologically tested spermatozoa is a safe way for human immunodeficiency type 1 virus-serodiscordant couples with an infected male partner to have a child. Fertil Steril 82(4):857–862. doi:10.​1016/​j.​fertnstert.​2004.​02.​128 PubMedCrossRef
17.
Garrido N, Meseguer M, Simon C, Pellicer A, Remohi J (2004) Assisted reproduction in HIV and HCV infected men of serodiscordant couples. Arch Androl 50(2):105–111. L08VW6L2GRQWQGMV [pii]PubMed
18.
Nicopoullos JD, Almeida PA, Ramsay JW, Gilling-Smith C (2004) The effect of human immunodeficiency virus on sperm parameters and the outcome of intrauterine insemination following sperm washing. Hum Reprod 19(10):2289–2297. doi:10.​1093/​humrep/​deh426 PubMedCrossRef
19.
Moyle G (2004) Mitochondrial toxicity: myths and facts. J HIV Ther 9(2):45–47PubMed
20.
Crittenden JA, Handelsman DJ, Stewart GJ (1992) Semen analysis in human immunodeficiency virus infection. Fertil Steril 57(6):1294–1299PubMed
21.
Dondero F, Rossi T, D’Offizi G, Mazzilli F, Rosso R, Sarandrea N, Pinter E, Aiuti F (1996) Semen analysis in HIV seropositive men and in subjects at high risk for HIV infection. Hum Reprod 11(4):765–768PubMed
22.
Dulioust E, Du AL, Costagliola D, Guibert J, Kunstmann JM, Heard I, Juillard JC, Salmon D, Leruez-Ville M, Mandelbrot L, Rouzioux C, Sicard D, Zorn JR, Jouannet P, De Almeida M (2002) Semen alterations in HIV-1 infected men. Hum Reprod 17(8):2112–2118PubMedCrossRef
23.
Muller CH, Coombs RW, Krieger JN (1998) Effects of clinical stage and immunological status on semen analysis results in human immunodeficiency virus type 1-seropositive men. Andrologia 30(Suppl 1):15–22PubMed
24.
Krieger JN, Coombs RW, Collier AC, Koehler JK, Ross SO, Chaloupka K, Murphy VL, Corey L (1991) Fertility parameters in men infected with human immunodeficiency virus. J Infect Dis 164(3):464–469PubMedCrossRef
25.
Brinkman K, ter Hofstede HJ, Burger DM, Smeitink JA, Koopmans PP (1998) Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway. AIDS 12(14):1735–1744PubMedCrossRef
26.
Carr A, Miller J, Law M, Cooper DA (2000) A syndrome of lipoatrophy, lactic acidemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome. AIDS 14(3):F25–F32PubMedCrossRef
27.
Bujan L, Sergerie M, Moinard N, Martinet S, Porte L, Massip P, Pasquier C, Daudin M (2007) Decreased semen volume and spermatozoa motility in HIV-1-infected patients under antiretroviral treatment. J Androl 28(3):444–452. doi:10.​2164/​jandrol.​106.​001529 CrossRef
28.
Garrido N, Meseguer M, Remohí J, Simón C, Pellicer A (2005) Semen characteristics in human immunodeficiency virus (HIV)- and hepatitis C (HCV)-seropositive males: predictors of the success of viral removal after sperm washing. Hum Reprod 20(4):1028–1034. doi:deh699[pii]10.​1093/​humrep/​deh699 PubMedCrossRef
29.
30.
31.
32.
Robbins WA, Witt KL, Haseman JK, Dunson DB, Troiani L, Cohen MS, Hamilton CD, Perreault SD, Libbus B, Beyler SA, Raburn DJ, Tedder ST, Shelby MD, Bishop JB (2001) Antiretroviral therapy effects on genetic and morphologic end points in lymphocytes and sperm of men with human immunodeficiency virus infection. J Infect Dis 184(2):127–135. doi:10.​1086/​322002 PubMedCrossRef
33.
Folgerø T, Bertheussen K, Lindal S, Torbergsen T, Oian P (1993) Mitochondrial disease and reduced sperm motility. Hum Reprod 8(11):1863–1868PubMed
34.
Ruiz-Pesini E, Diez C, Lapeña AC, Pérez-Martos A, Montoya J, Alvarez E, Arenas J, López-Pérez MJ (1998) Correlation of sperm motility with mitochondrial enzymatic activities. Clin Chem 44(8 Pt 1):1616–1620PubMed
35.
May-Panloup P, Chrétien MF, Savagner F, Vasseur C, Jean M, Malthièry Y, Reynier P (2003) Increased sperm mitochondrial DNA content in male infertility. Hum Reprod 18(3):550–556PubMedCrossRef
36.
37.
38.
Brinkman K, Smeitink JA, Romijn JA, Reiss P (1999) Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy. Lancet 354(9184):1112–1115. doi:10.​1016/​S0140-6736(99)06102-4 PubMedCrossRef
39.
Casula M, Weverling GJ, Wit FW, Timmermans EC, Stek M Jr, Lange JM, Reiss P (2005) Mitochondrial DNA and RNA increase in peripheral blood mononuclear cells from HIV-1-infected patients randomized to receive stavudine-containing or stavudine-sparing combination therapy. J Infect Dis 192(10):1794–1800. doi:10.​1086/​497140 PubMedCrossRef
40.
Phenix BN, Angel JB, Mandy F, Kravcik S, Parato K, Chambers KA, Gallicano K, Hawley-Foss N, Cassol S, Cameron DW, Badley AD (2000) Decreased HIV-associated T cell apoptosis by HIV protease inhibitors. AIDS Res Hum Retroviruses 16(6):559–567. doi:10.​1089/​088922200308972 PubMedCrossRef
41.
Sloand EM, Kumar PN, Kim S, Chaudhuri A, Weichold FF, Young NS (1999) Human immunodeficiency virus type 1 protease inhibitor modulates activation of peripheral blood CD4(+) T cells and decreases their susceptibility to apoptosis in vitro and in vivo. Blood 94(3):1021–1027PubMed
Metadaten
Titel
HIV-infection and modern antiretroviral therapy impair sperm quality
verfasst von
Sven Kehl
Michael Weigel
Daniel Müller
Monika Gentili
Amadeus Hornemann
Marc Sütterlin
Publikationsdatum
01.07.2011
Verlag
Springer-Verlag
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 1/2011
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-011-1898-6

Weitere Artikel der Ausgabe 1/2011

Archives of Gynecology and Obstetrics 1/2011 Zur Ausgabe

General Gynecology

Group A streptococcal vaginitis: an unrecognized cause of vaginal symptoms in adult women

Materno-fetal Medicine

Infant births during the internal night are at increased risk for operative delivery and NICU admission

Gynecologic Oncology

The prognostic and predictive value of CA-125 regression during neoadjuvant chemotherapy for advanced ovarian or primary peritoneal carcinoma

General Gynecology

Vaginal hysterectomy with bipolar coagulation forceps (BiClamp) as an alternative to the conventional technique

Materno-fetal Medicine

Pregnancy outcome in women with autoimmune hepatitis

Materno-fetal Medicine

Randomized trial of oral versus sublingual misoprostol 24 h after mifepristone for medical abortion

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

23.04.2024 Medikamente in Schwangerschaft und Stillzeit Nachrichten

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen
Bildnachweise